首頁 > 市場調查報告書 > 製藥

藥物開發

市場調查報告書

商品編碼

1532480

化學資訊學市場- 按產品類型（軟體、服務）、應用（化學分析[化學計量學、分子建模]、虛擬篩選、藥物發現和驗證）、最終用途（CRO、製藥、生物技術公司） - 全球預測（2024 年- 2032 年））

Chemoinformatics Market - By Product Type (Software, Service), Application (Chemical Analysis [Chemometrics, Molecular Modelling], Virtual Screening, Drug Discovery & Validation), End-use (CRO, Pharma, Biotech Companies) - Global Forecast (2024 - 2032)

出版日期: 2024年05月17日 | 出版商:

Global Market Insights Inc. | 英文 170 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

由於製藥業對先進藥物發現和開發流程的需求不斷成長，化學資訊學市場規模從 2024 年到 2032 年可能會實現 15.5% 的複合年成長率。化學資料與資訊技術的整合使得複雜化學資訊的高效分析和視覺化成為可能，這對於識別潛在候選藥物和最佳化先導化合物至關重要。例如，2024 年 1 月，德勤推出了 Atlas AI，這是其 Quartz AI™ 套件的突破性補充，代表了生命科學和醫療保健領域的重大進步。

在環境科學中，化學資訊學用於研究化學品對生態系統和人類健康的影響，有助於開發更安全的化學品和遵守法規。在材料科學中，它有助於設計和發現具有所需特性的新材料。計算化學的不斷進步和化學資料的不斷增加也將支持市場的成長。

整個產業分為產品類型、應用、最終用途和地區。

根據產品類型，服務領域的化學資訊學市場規模預計將在 2024 年至 2032 年間產生可觀的收入，因為它為各行業的實施和最佳化提供了重要的支援和專業知識。化學資訊學服務包括諮詢、客製化軟體開發、培訓和資料分析，可幫助組織有效地融入其工作流程，從而最大限度地提高化學資料的效用和效率。

在應用方面，化學資訊學產業將在 2032 年之前實現顯著的成長。虛擬篩選顯著減少了與傳統實驗室篩選方法相關的時間和成本，使研究人員能夠快速且準確地預測化合物的生物活性。

由於中國、印度和日本製藥和生物技術產業的快速擴張，到 2032 年，亞太地區化學資訊學市場規模將以複合年成長率大幅成長。這些國家擴大投資於藥物發現和開發，以簡化流程並提高研究效率。政府支持科學研究、創新和數位轉型的措施將進一步推動區域市場的成長。

產業生態系統分析
產業影響力
- 成長動力
  - 增加製藥和生技產業的研發活動
  - 對個人化醫療和精準醫療保健的需求不斷成長
  - 計算技術的進步
- 產業陷阱與挑戰
  - 數據品質和可用性
  - 演算法偏差和可解釋性
成長潛力分析
監管環境
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場估計與預測：按產品類型，2021 - 2032

主要趨勢
軟體
服務

第 6 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
化學分析
- 化學資料庫
- 化學計量學
- 分子建模
- 其他化學分析類型
藥物發現與驗證
虛擬篩選
其他應用

第 7 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
製藥和生物技術公司
學術及研究機構
合約研究組織 (CRO)
其他最終用戶

第 8 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 荷蘭
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

ACD/Labs, Inc.
Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
BioSolveIT GmbH
Cadence Molecular Sciences LLC
Centara
ChemAxon Ltd
Chemical Computing Group ULC
Collaborative Drug Discovery Inc.
Dassault Systemes
Jubilant Biosys Ltd
Molecular Discovery Ltd
OpenEye Scientific Software, Inc.
PerkinElmer Inc.
Schrodinger, Inc.
Scilligence

簡介目錄

Product Code: 9527

Chemoinformatics market size is likely to register a 15.5% CAGR from 2024-2032 driven by the increasing demand for advanced drug discovery and development processes in the pharmaceutical industry. The integration of chemical data with information technology is enabling the efficient analysis and visualization of complex chemical information, which is crucial for identifying potential drug candidates and optimizing lead compounds. For instance, in January 2024, Deloitte introduced Atlas AI, a groundbreaking addition to its Quartz AI(TM) suite, representing a significant advancement in the fields of life sciences and healthcare.

In environmental science, chemoinformatics is used to study the impact of chemicals on ecosystems and human health, aiding in the development of safer chemicals and regulatory compliance. In materials science, it helps in the design and discovery of new materials with desired properties. The continuous advancements in computational chemistry and the growing availability of chemical data will also support the market growth.

The overall industry is classified into product type, application, end-use, and region.

Based on product type, the chemoinformatics market size from the services segment is poised to generate substantial revenue between 2024 and 2032 owing to its essential support and expertise for the implementation and optimization across various industries. Chemoinformatics services, which include consulting, custom software development, training, and data analysis, help organizations effectively integrate into their workflows for maximizing the utility and efficiency of their chemical data.

In terms of application, the chemoinformatics industry will record a significant growth rate through 2032. This is backed by the need for revolutionizing the drug discovery process through computational methods that efficiently identify potential drug candidates from vast chemical libraries. Virtual screening significantly reduces the time and cost associated with traditional laboratory-based screening methods, enabling researchers to quickly and accurately predict the biological activity of compounds.

Asia Pacific chemoinformatics market size will grow at substantial CAGR through 2032 attributed to the rapid expansion of the pharmaceutical and biotechnology sectors in China, India, and Japan. These countries are increasingly investing in drug discovery and development for leveraging to streamline processes and enhance research efficiency. Government initiatives for supporting scientific research, innovation, and digital transformation will further fuel the regional market growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing R&D activities in pharmaceutical and biotechnology industries
  - 3.2.1.2 Rising demand for personalized medicine and precision healthcare
  - 3.2.1.3 Advancements in computational technologies
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Data quality and availability
  - 3.2.2.2 Algorithmic bias and interpretability
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Software
5.3 Services

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Chemical analysis
- 6.2.1 Chemical databases
- 6.2.2 Chemometrics
- 6.2.3 Molecular modelling
- 6.2.4 Other chemical analysis types
6.3 Drug discovery and validation
6.4 Virtual screening
6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Pharmaceutical and biotechnology companies
7.3 Academic and research institutes
7.4 Contract research organizations (CROs)
7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa